Alessandro Riva's most recent trade in Century Therapeutics Inc was a trade of 44,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Century Therapeutics Inc | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| BeiGene Ltd - ADR | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 22,750 | 22,750 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 10,985 | 56,940 (0%) | 0% | 0 | Ordinary Shares | |
| Bicycle Therapeutics Plc -... | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Bicycle Therapeutics Plc -... | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2025 | 12,500 | 12,500 | - | 0 | Ordinary Shares | |
| Century Therapeutics Inc | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| BeiGene Ltd - ADR | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 34,151 | 34,151 | - | - | Share Option (Right to Buy) | |
| BeiGene Ltd - ADR | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 16,341 | 45,955 (0%) | 0% | 0 | Ordinary Shares | |
| Century Therapeutics Inc | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 19,872 | 19,872 | - | - | Stock Option (right to buy) | |
| Century Therapeutics Inc | Alessandro Riva | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 19,872 | 19,872 | - | - | Option (right to buy) |